Stay updated on Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial

Sign up to get notified when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update in the study related to evaluating whether MST-188 can reduce the duration of vaso-occlusive crisis in subjects with sickle cell disease.
    Difference
    0.1%
    Check dated 2024-06-06T14:40:07.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed participation criteria for the study, specifying eligibility requirements such as age range, confirmed diagnosis, and current health condition, replacing the previous placeholder text that indicated no information was provided.
    Difference
    10%
    Check dated 2024-05-22T21:28:52.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:49:21.000Z thumbnail image

Stay in the know with updates to Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.